These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1553790)

  • 1. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.
    Schwille PO; Herrmann U; Wolf C; Berger I; Meister R
    Urol Res; 1992; 20(2):145-55. PubMed ID: 1553790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients.
    Herrmann U; Schwille PO; Schwarzlaender H; Berger I; Hoffmann G
    Urol Res; 1992; 20(5):347-53. PubMed ID: 1455567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
    Berg C; Larsson L; Tiselius HG
    J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
    Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
    J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute oral alkali citrate load in healthy humans--response of blood and urinary citrate, mineral metabolism, and factors related to stone formation.
    Schwille PO; Weippert JH; Bausch W; Rümenapf G
    Urol Res; 1985; 13(4):161-8. PubMed ID: 4049601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical effects of potassium citrate in the treatment of calcium oxalate lithiasis].
    Conte Visús A; Ibarz Servio L; Arrabal Martín M; Ibarz Navarro JM; Ruiz Marcellán FJ
    Arch Esp Urol; 1994 Mar; 47(2):141-50. PubMed ID: 8002670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies of citrate therapy on urolithiasis--estimations of urinary citrate excretion in patients with urolithiasis and the results of treatment with sodium-potassium citrate].
    Yasukawa S
    Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):620-8. PubMed ID: 3226014
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of acute oral sodium potassium citrate load in healthy males--outlook for treatment of patients with calcium-containing renal stones.
    Schwille PO; Rümenapf G; Köhler R; Sörgel F
    Urol Int; 1987; 42(2):81-8. PubMed ID: 3617247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate.
    Berg C; Larsson L; Tiselius HG
    Urol Res; 1990; 18(1):13-6. PubMed ID: 2316066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
    Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
    Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate.
    Jendle-Bengten C; Tiselius HG
    Scand J Urol Nephrol; 2000 Feb; 34(1):36-41. PubMed ID: 10757268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
    Pak CY; Fuller C
    Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of routine citrate analysis and calcium/citrate ratio in calcium urolithiasis.
    Höbarth K; Hofbauer J
    Eur Urol; 1991; 19(2):165-8. PubMed ID: 2022221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is magnesium a marker of disordered mineral metabolism in males with idiopathic recurrent calcium urolithiasis? Observations focussing on fasting magnesiuria and magnesiemia, protein and other substances in urine and plasma.
    Schmiedl A; Schwille PO
    Magnes Res; 2003 Sep; 16(3):192-205. PubMed ID: 14596324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):918-31. PubMed ID: 3051946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.